Rx Regulatory Puzzle: FDA’s 2015 Agenda Comes Together Piece By Piece
Executive Summary
Generic drug labeling, drug shortages and compounding will be tackled in regulations in 2015; three documents weave together a picture of FDA’s upcoming actions on pharmaceutical-related rules.